Matching slides 303,780
Current window 206,581-206,610
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all

Component

206,581-206,610 of 303,780

filter-aware
63
Mink Therapeutics | Investor Day Presentation Deck | 92 slidesMink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
64
The slide uses a 'Our World in Data' chart to provide context for the mortality rates listed on the left.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
66
The slide uses a combination of medical illustration and real-world clinical photography to explain the procedure.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
67
Clinical trial data summary table.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
68
The slide uses a Kaplan-Meier survival curve, a frequency table for adverse events, and box-and-whisker plots for cytokine levels.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
69
Data presented by Saint John's Cancer Institute for MiNK Therapeutics.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
70
Mink Therapeutics | Investor Day Presentation Deck | 92 slidesMink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
72
Mink Therapeutics | Investor Day Presentation Deck | 92 slidesMink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
73
The slide uses a dual-panel layout to contrast pro-inflammatory responses in solid tumors with anti-inflammatory responses in ARDS.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
76
The slide uses a numbered list format to categorize distinct barriers: tumor heterogeneity, trafficking, microenvironment, and product quality.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
77
Mink Therapeutics | Investor Day Presentation Deck | 92 slidesMink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
78
The slide uses a visual metaphor of a competition with a trophy to declare iNKT the winner.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
79
The slide uses a visual comparison framework to contrast iNKT cell capabilities against traditional ACT limitations.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
80
Mink Therapeutics | Investor Day Presentation Deck | 92 slidesMink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
81
Mink Therapeutics | Investor Day Presentation Deck | 92 slidesMink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
82
The slide depicts a mechanism of immune evasion via metabolic competition and immunosuppressive signaling.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
83
The slide uses scRNA-seq data to correlate cell states (Steady State, 4h, 72h post-activation) with specific metabolic gene modules.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
84
Includes a cartoon illustration of a person cooking, likely representing a researcher or experimental process.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
85
The slide depicts a xenograft model setup.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
86
Flow cytometry plots show higher purity/persistence for Gen 2. Bar charts show statistically significant differences (*) in cell count, tumor volume, and metabolic markers.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
87
Uses a visual metaphor to explain biological versatility.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
88
The slide uses UMAP dimensionality reduction to visualize gene expression density across cell populations.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
89
Scientific visualization of immune cell behavior in adipose tissue.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
90
Data from Lynch et al. Nature Immunology 2015 and Lynch et al. Immunity 2012.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
91
The Swiss Army knife is a visual metaphor for the versatility of the cells.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
92
Mink Therapeutics | Investor Day Presentation Deck | 92 slidesMink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
02
Morgan Stanley | Fixed Income Presentation Deck | 11 slidesMorgan Stanley | Fixed Income Presentation Deck | 11 slides · Morgan Stanley
Conference presentation Investor relations 1 hit
03
Includes footnotes referencing specific financial metrics and reporting periods.Morgan Stanley | Fixed Income Presentation Deck | 11 slides · Morgan Stanley
Conference presentation Investor relations 1 hit
04
Includes four charts: two bar charts, one stacked bar chart, and one donut chart.Morgan Stanley | Fixed Income Presentation Deck | 11 slides · Morgan Stanley
Conference presentation Investor relations 1 hit
05
The slide includes a stacked bar chart showing funding composition from 2017 to 3Q22, alongside descriptive boxes for each funding category.Morgan Stanley | Fixed Income Presentation Deck | 11 slides · Morgan Stanley
Conference presentation Investor relations 1 hit